Prophylactic metformin after antenatal corticosteroids (PROMAC): A double blind randomized controlled trial
Background: Antenatal corticosteroids (ACS) are increasingly used to improve prematurity-related neonatal outcome. A recognized and common adverse effect from administration of antenatal corticosteroid is maternal hyperglycemia. Even normal pregnancy is characterized by relative insulin resistance a...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
BioMed Central
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/26635/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|